Lubbock, TX, United States of America

Ashwin Ramanujam

This inventor holds 2 USPTO granted patents. Top assignee: Texas Tech University System. Active years: 2021-2026.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ashwin Ramanujam: Innovator in Rapid Viral Diagnostics

Introduction

Ashwin Ramanujam is a notable inventor based in Lubbock, Texas. He has made significant contributions to the field of rapid viral diagnostics, particularly in the context of emerging pandemic threats. His work focuses on developing innovative solutions that can enhance the speed and efficiency of virus detection.

Latest Patents

Ashwin Ramanujam holds a patent for a device known as the Rapid Viral Diagnostic Sensor. This invention provides a method for the rapid detection of viruses and virions, including those associated with the novel coronavirus (SARS-CoV-2) and Human Immunodeficiency Virus (HIV). The device is designed for use in various settings, such as hospitals, clinical laboratories, airports, and even homes. It can function as a single-use probe or be integrated into a carousel for simultaneous testing of multiple samples, which is particularly useful during pandemics when rapid testing is crucial.

Career Highlights

Ashwin Ramanujam is affiliated with the Texas Tech University System, where he continues to advance his research and development efforts. His work is characterized by a commitment to addressing public health challenges through innovative technology.

Collaborations

One of his notable collaborators is Gerardine G Botte, with whom he has worked on various projects related to viral diagnostics.

Conclusion

Ashwin Ramanujam's contributions to rapid viral diagnostics exemplify the importance of innovation in public health. His patented technology has the potential to significantly improve virus detection and response during health crises.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…